Followers | 679 |
Posts | 140848 |
Boards Moderated | 36 |
Alias Born | 03/10/2004 |
Wednesday, November 02, 2022 11:41:19 AM
By: Barchart | November 2, 2022
CVS Health booked a third-quarter loss of more than $3 billion after setting aside money for a potential opioid litigation deal but still beat expectations and raised its 2022 forecast.
The health care giant detailed on Wednesday a planned nationwide settlement of lawsuits over how it has handled prescriptions for powerful painkillers linked to an overdose epidemic.
The company recorded in the recently completed quarter a $5.2 billion pretax charge for the settlement. That covers payments over 10 years, starting next year.
CVS CEO Karen Lynch told analysts Wednesday morning that the company has a “high degree of confidence” that states will accept the deal. She noted that state attorneys general were at the negotiating table when CVS Health began discussions late last month.
CVS Health also recorded a $2.5 billion loss in the quarter on assets held for sale to write down the company’s struggling Omnicare long-term care business. Lynch told analysts the company was “actively exploring strategic alternatives” for the business.
CVS Health also saw sales growth in the quarter from all three of its main businesses as total revenue climbed 10% to $81.2 billion.
Adjusted earnings, which don't count one-time items like the settlement, totaled $2.09 per share.
Analysts expected, on average, adjusted earnings of $2 per share on $76.74 billion in revenue, according to FactSet.
CVS operates one of the nation’s largest drugstore chains with nearly 10,000 retail locations. It runs prescription drug plans for big clients like insurers and employers through a large pharmacy benefit management business.
It also provides health insurance for more than 24 million people through its Aetna arm.
Prescription growth fueled an 11% jump in revenue from the company's largest segment, the pharmacy benefit management business.
The ongoing COVID-19 pandemic also continues to help sales. Company leaders said they expect more than $3 billion in revenue this year from vaccinations, diagnostic testing for the virus and test kits sold over the counter or without a prescription. But Chief Financial Officer Shawn Guertin cautioned against expecting a similar level of sales going forward.
CVS Health now expects adjusted earnings of $8.55 to $8.65 per share for this year, a higher and narrower forecast than it made in August.
FactSet says analysts predict, on average, earnings of $8.55 per share.
Guertin said CVS Health's initial goal for 2023 is to grow adjusted earnings to a range of $8.70 to $8.90 per share. The company will provide a detailed forecast early next year.
Analysts are looking for $9.07 per share next year.
Shares of CVS Health Corp., based in Woonsocket, Rhode Island, climbed 4%, or $3.89, to $98.51 Wednesday morning while broader indexes slipped.
Read Full Story »»»
DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold
Recent CVS News
- CVS Health opens new workforce development and community resource center in Baton Rouge • PR Newswire (US) • 04/25/2024 01:00:00 PM
- CVS Health invests $19.2 million in affordable housing in Arvada, Colorado • PR Newswire (US) • 04/24/2024 01:00:00 PM
- Baum Family Investments Embarks on Triple Net Lease Strategy with $250 Million Acquisition Goal • PR Newswire (US) • 04/23/2024 08:10:00 PM
- Aetna Better Health of Michigan recommended for CHCP contract • PR Newswire (US) • 04/09/2024 04:00:00 PM
- CVS Health® expands pharmacy tuition assistance and scholarship programs • PR Newswire (US) • 04/03/2024 12:00:00 PM
- CVS Health to hold first quarter 2024 earnings conference call • PR Newswire (US) • 04/01/2024 01:00:00 PM
- CVS Health® invests more than $3M in organizations improving health outcomes in Phoenix • PR Newswire (US) • 03/27/2024 06:00:00 PM
- CVS Health announces quarterly dividend • PR Newswire (US) • 03/21/2024 02:55:00 PM
- AM Best Affirms Credit Ratings of Most of CVS Health Corporation’s Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna • Business Wire • 03/13/2024 09:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:09:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:21:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:20:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:18:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 09:37:48 PM
- CVS Health invests nearly $35 million in affordable housing in Hawai'i • PR Newswire (US) • 02/22/2024 01:45:00 AM
- CVS Health to participate at the 45nd Annual Raymond James Institutional Investors Conference • PR Newswire (US) • 02/21/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:46:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 09:12:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:15:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:14:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:13:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:12:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 10:08:19 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 10:02:40 PM
- Form 13F-HR - Quarterly report filed by institutional managers, Holdings • Edgar (US Regulatory) • 02/09/2024 10:14:24 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM